Wrapping up Q1 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...

Shares of Charles River Laboratories (NYSE:CRL) climbed ~21% in the premarket on Wednesday after the Massachusetts-based ...

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies ...

Charles River Laboratories International, Inc.’s CRL share price has surged by 15.85%, which has investors questioning if ...

By Siddhi Mahatole and Sriparna Roy (Reuters) -Charles River Laboratories shares jumped 15% on Wednesday after the company raised its annual profit forecast due to improving demand for contract drug ...

Charles River Laboratories (NYSE:CRL) announced Wednesday it will appoint four new directors to its board and launch a comprehensive strategic review following a cooperation agreement with activist ...

Charles River CEO James Foster had previously attributed the 2024 revenue dip to decreased demand from biopharma clients. In ...

WILMINGTON, Mass. (AP) — WILMINGTON, Mass. (AP) — Charles River Laboratories International Inc. (CRL) on Wednesday reported first-quarter profit of $25.5 million. On a per-share basis, the Wilmington, ...